Yantao I. Xu
600 Tianhe Road
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study.
Journal: The Journal of dermatological treatment
Published: April 01, 2026
Insight of immune checkpoint blockades in melanoma: mechanism and clinical translation.
Journal: Molecular cancer
Published: January 16, 2026
Multi-omics analysis reveals CXCL14+ inhibitory neuron dysfunction in major depressive disorder.
Journal: Journal of affective disorders
Published: November 21, 2025
From Gene to Scar: Proteome-Wide Causal Insights into Keloid Pathogenesis and Prevention.
Journal: Advances in wound care
Published: November 05, 2025
Construction of dunaliella salina-derived exosome-like nanovesicles co-delivery system for ICG and 5-FU and its enhanced suppression in triple-negative breast cancer cell.
Journal: Nanotechnology
Published: September 24, 2025
Matrix stiffness drives squamous cell carcinoma progression via a Piezo1-mediated mechanotransduction feedback loop.
Journal: Journal of advanced research
Published: July 19, 2025
Decoding the air pollutant-psoriasis axis: A multi-layered systems toxicology investigation.
Journal: Ecotoxicology and environmental safety
Published: March 30, 2025
Corrigendum to "Size-specific clonidine-loaded liposomes: Advancing melanoma microenvironment suppression with safety and precision" [Journal of Controlled Release, Volume 379, 10 March 2025, Pages 120-134].
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 21, 2025
Genetic imputation of transcriptome and proteome illuminates novel therapeutic targets of cutaneous melanoma.
Journal: Briefings in bioinformatics
Published: February 13, 2025
The progress and prospects of targeting the adenosine pathway in cancer immunotherapy.
Journal: Biomarker research
Published: February 08, 2025
Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agent in psychiatric and neurodevelopmental conditions: evidence from a drug target Mendelian randomization.
Journal: BMC psychiatry
Published: November 04, 2024
Last Updated: 09/26/2026